← Back to patent-cliff list
酒石酸西尼必利/奥美拉唑
Tier C — Watch / tradeCinitapride Tartrate/Omeprazole
Zydus Cadila
Originator
2010
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：5-HT2、Proton pump、5-HT4、5-HT1A
Brand：Burpex
Indications (approved)：胃溃疡、胃食管反流病、消化不良
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Cinitapride Tartrate/Omeprazole?
Approved indications include: 胃溃疡, 胃食管反流病, 消化不良.
When does the Cinitapride Tartrate/Omeprazole patent expire?
No public expiry year is available for Cinitapride Tartrate/Omeprazole yet; this page updates once verified.
How do I get a quote for Cinitapride Tartrate/Omeprazole intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24